Skip to main content
SpringerLink
Log in

Pediatric Genitourinary Tumor Imaging

  • Chapter
  • First Online:
Atlas of Genitourinary Oncological Imaging

Part of the book series: Atlas of Oncology Imaging ((AOI,volume 1))

  • 2318 Accesses

Abstract

Wilms tumor (4 %) and neuroblastoma (8 %) make up the largest group of extracranial solid tumors of childhood. Most of these patients present before 5 years of age. Mesoblastic nephroma and stage IVS neuroblastoma are seen in children less than 1 year of age. Several other primary renal tumors may be seen in children. Adrenocortical carcinoma and pheochromocytoma are rare. The imaging features of these tumors will be shown. Rhabdomyosarcoma of the bladder will also be discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Li J. Cancer incidence among children and adolescents in the United States, 2001–2003. Pediatrics. 2008;121:e1470.

    Article  PubMed  Google Scholar 

  2. Lowe LH, Isuani BH, Heller RM, et al. Pediatric renal masses: Wilms tumor and beyond. Radiographics. 2000;20:1585–603.

    PubMed  CAS  Google Scholar 

  3. National Cancer Institute. Wilms tumor and other childhood kidney tumors treatment (PDQ). Available at http://www.cancer.gov/cancertopics/pdq/treatment/wilms/Patient/page1. Accessed 24 Jan 2012.

  4. Miniati D, Gay AN, Parks KV, et al. Imaging accuracy and incidence of Wilms’ and non-Wilms’ renal tumors in children. J Pediatr Surg. 2008;43:1301–7.

    Article  PubMed  Google Scholar 

  5. Mullen EA, Weldon C, Kreidberg JA. Pediatric renal tumors. In: Ellis Avner WH, Niaudet P, Norishige Y, editors. Pediatric nephrology. 6th ed. Berlin/Heidelberg: Springer; 2009. p. 1431–55.

    Chapter  Google Scholar 

  6. Chaudry G, Perez-Atayde AR, Ngan BY, et al. Imaging of congenital mesoblastic nephroma with pathological correlation. Pediatr Radiol. 2009;39:1080–6.

    Article  PubMed  Google Scholar 

  7. Rohrschneider WK, Weirich A, Rieden K, et al. US, CT and MR imaging characteristics of nephroblastomatosis. Pediatr Radiol. 1998;28:435–43.

    Article  PubMed  CAS  Google Scholar 

  8. Owens CM, Brisse HJ, Olsen OE, et al. Bilateral disease and new trends in Wilms tumour. Pediatr Radiol. 2008;38:30–9.

    Article  PubMed  Google Scholar 

  9. Sethi AT, Narla LD, Fitch SJ, et al. Best cases from the AFIP: Wilms tumor in the setting of bilateral nephroblastomatosis. Radiographics. 2010;30:1421–5.

    Article  PubMed  Google Scholar 

  10. Ritchey M, Daley S, Shamberger RC, et al. Ureteral extension in Wilms’ tumor: a report from the National Wilms’ Tumor Study Group (NWTSG). J Pediatr Surg. 2008;43:1625–9.

    Article  PubMed  Google Scholar 

  11. Rutigliano DN, Kayton ML, Steinherz P, et al. The use of preoperative chemotherapy in Wilms’ tumor with contained retroperitoneal rupture. J Pediatr Surg. 2007;42:1595–9.

    Article  PubMed  Google Scholar 

  12. Siegel MJ, Chung EM. Wilms’ tumor and other pediatric renal masses. Magn Reson Imaging Clin N Am. 2008;16:479–97. vi.

    Article  PubMed  Google Scholar 

  13. Smets AM, de Kraker J. Malignant tumours of the kidney: imaging strategy. Pediatr Radiol. 2010;40:1010–8.

    Article  PubMed  Google Scholar 

  14. Taguchi S, Shono T, Mori D, et al. Extrarenal Wilms tumor in children with unfavorable histology: a case report. J Pediatr Surg. 2010;45:e19–22.

    Article  PubMed  Google Scholar 

  15. Blitman NM, Berkenblit RG, Rozenblit AM, et al. Renal medullary carcinoma: CT and MRI features. AJR Am J Roentgenol. 2005;185:268–72.

    Article  PubMed  Google Scholar 

  16. Hakimi AA, Koi PT, Milhoua PM, et al. Renal medullary carcinoma: the Bronx experience. Urology. 2007;70:878–82.

    Article  PubMed  Google Scholar 

  17. Armah HB, Parwani AV, Surti U, et al. Xp11.2 translocation renal cell carcinoma occurring during pregnancy with a novel translocation involving chromosome 19: a case report with review of the literature. Diagn Pathol. 2009;4:15.

    Article  PubMed  Google Scholar 

  18. Fleitz JM, Wootton-Gorges SL, Wyatt-Ashmead J, et al. Renal cell carcinoma in long-term survivors of advanced stage neuroblastoma in early childhood. Pediatr Radiol. 2003;33:540–5.

    Article  PubMed  Google Scholar 

  19. Abramson SJ, Price AP. Imaging of pediatric lymphomas. Radiol Clin North Am. 2008;46:313–38. ix.

    Article  PubMed  Google Scholar 

  20. Wong-You-Cheong JJ, Woodward PJ, Manning MA, et al. From the archives of the AFIP: neoplasms of the urinary bladder: radiologic-pathologic correlation. Radiographics. 2006;26:553–80.

    Article  PubMed  Google Scholar 

  21. National Cancer Institute. Childhood rhabdomyosarcoma treatment (PDQ). Available at http://wwwcancergov/cancertopics/pdq/treatment/childrhabdomyosarcoma/HealthProfessional/page5 2010. Accessed 25 Jan 2012.

  22. Pappo A. Pediatric bone and soft tissue sarcomas. Berlin/New York: Springer; 2006.

    Book  Google Scholar 

  23. Arndt C, Rodeberg D, Breitfeld PP, et al. Does bladder preservation (as a surgical principle) lead to retaining bladder function in bladder/prostate rhabdomyosarcoma? Results from intergroup rhabdomyosarcoma study iv. J Urol. 2004;171:2396–403.

    Article  PubMed  Google Scholar 

  24. Grovas A, Fremgen A, Rauck A, et al. The National Cancer Data Base report on patterns of childhood cancers in the United States. Cancer. 1997;80:2321–32.

    Article  PubMed  CAS  Google Scholar 

  25. Gurney JG, Ross JA, Wall DA, et al. Infant cancer in the U.S.: histology-specific incidence and trends, 1973 to 1992. J Pediatr Hematol Oncol. 1997;19:428–32.

    Article  PubMed  CAS  Google Scholar 

  26. Kushner BH, Kramer K, LaQuaglia MP, et al. Neuroblastoma in adolescents and adults: the Memorial Sloan-Kettering experience. Med Pediatr Oncol. 2003;41:508–15.

    Article  PubMed  Google Scholar 

  27. DuBois SG, Kalika Y, Lukens JN, et al. Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival. J Pediatr Hematol Oncol. 1999;21:181–9.

    Article  PubMed  CAS  Google Scholar 

  28. Abramson SJ BW, Ruzal-Shapiro C, et al. Cervical neuroblastoma in eleven infants: a tumor with favorable prognosis. Clinical and radiologic (US, CT, MRI) findings. Pediatr Radiol. 1993;23:253–7.

    Article  PubMed  Google Scholar 

  29. Abramson SJ BW, Stolar C. Stage lV N neuroblastoma: MRI diagnosis of left supraclavicular “Virchow’s” nodal spread. Pediatr Radiol. 1996;26:717–9.

    Article  PubMed  Google Scholar 

  30. Cowie F, Corbett R, Pinkerton CR. Lung involvement in neuroblastoma: incidence and characteristics. Med Pediatr Oncol. 1997;28:429–32.

    Article  PubMed  CAS  Google Scholar 

  31. Kammen BF, Matthay KK, Pacharn P, et al. Pulmonary metastases at diagnosis of neuroblastoma in pediatric patients: CT findings and prognosis. AJR Am J Roentgenol. 2001;176:755–9.

    Article  PubMed  CAS  Google Scholar 

  32. Matthay KK, Brisse H, Couanet D, et al. Central nervous system metastases in neuroblastoma: radiologic, clinical, and biologic ­features in 23 patients. Cancer. 2003;98:155–65.

    Article  PubMed  Google Scholar 

  33. D’Ambrosio N, Lyo JK, Young RJ, et al. Imaging of metastatic CNS neuroblastoma. AJR Am J Roentgenol. 2010;194:1223–9.

    Article  PubMed  Google Scholar 

  34. Kramer K, Kushner BH, Modak S, et al. Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastoma. J Neurooncol. 2010;97:409–18.

    Article  PubMed  Google Scholar 

  35. Croog VJ, Kramer K, Cheung NK, et al. Whole neuraxis irradiation to address central nervous system relapse in high-risk neuroblastoma. Int J Radiat Oncol Biol Phys. 2010;78:849–54.

    Article  PubMed  Google Scholar 

  36. Aronson M, Smoker WR, Oetting GM. Hemorrhagic intracranial parenchymal metastases from primary retroperitoneal neuroblastoma. Pediatr Radiol. 1995;25:284–5.

    Article  PubMed  CAS  Google Scholar 

  37. Brodeur GM, Pritchard J, Berthold F, et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol. 1993;11:1466–77.

    PubMed  CAS  Google Scholar 

  38. Shimada H, Ambros IM, Dehner LP, et al. Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer. 1999;86:349–63.

    Article  PubMed  CAS  Google Scholar 

  39. Brodeur GM, Fong CT. Molecular biology and genetics of human neuroblastoma. Cancer Genet Cytogenet. 1989;41:153–74.

    Article  PubMed  CAS  Google Scholar 

  40. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer. 2003;3:203–16.

    Article  PubMed  CAS  Google Scholar 

  41. Kaneko Y, Knudson AG. Mechanism and relevance of ploidy in neuroblastoma. Genes Chromosomes Cancer. 2000;29:89–95.

    Article  PubMed  CAS  Google Scholar 

  42. Kushner B. Neuroblastoma: a disease requiring a multitude of imaging studies. J Nucl Med. 2004;45:1172–88.

    PubMed  Google Scholar 

  43. Schmidt ML, Lukens JN, Seeger RC, et al. Biologic factors determine prognosis in infants with stage IV neuroblastoma: a prospective Children’s Cancer Group study. J Clin Oncol. 2000;18:1260–8.

    PubMed  CAS  Google Scholar 

  44. Castleberry RP, Pritchard J, Ambros P, et al. The International Neuroblastoma Risk Groups (INRG): a preliminary report. Eur J Cancer. 1997;33:2113–6.

    Article  PubMed  CAS  Google Scholar 

  45. Monclair T, Brodeur GM, Ambros PF, et al. The International Neuroblastoma Risk Group (INRG) staging system: an INRG Task Force report. J Clin Oncol. 2009;27:298–303.

    Article  PubMed  Google Scholar 

  46. Abramson SJ. Adrenal neoplasms in children. Radiol Clin North Am. 1997;35:1415–53.

    PubMed  CAS  Google Scholar 

  47. Tiedeman K, Pritchard J, Long R, et al. Intractable diarrhoea in a patient with vasoactive intestinal peptide-secreting neuroblastoma. Eur J Pediatr. 1981;137:217–9.

    Google Scholar 

  48. Altman A, Baehner RL. Favorable prognosis for survival in children with coincident opsomyoclonus and neuroblastoma. Cancer. 1976;37:846–52.

    Article  PubMed  CAS  Google Scholar 

  49. Baker ME, Kirks DR, Korobkin M, et al. The association of neuroblastoma and myoclonic encephalopathy: an imaging approach. Pediatr Radiol. 1984;15:185.

    Article  Google Scholar 

  50. Toma P, Lucigrai G, Marzoli A, et al. Prenatal diagnosis of metastatic adrenal neuroblastoma with sonography and MR imaging. AJR Am J Roentgenol. 1994;162:1183–4.

    Article  PubMed  CAS  Google Scholar 

  51. Sauvat F, Sarnacki S, Brisse H, et al. Outcome of suprarenal localized masses diagnosed durint the preinatal period: a retrospective multicenter study. Cancer. 2002;94:2474–80.

    Article  PubMed  Google Scholar 

  52. Yamamoto K, Hanada R, Kikuchi A, et al. Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol. 1998;16:1265–9.

    PubMed  CAS  Google Scholar 

  53. Woods WG, Gao RN, Shuster JJ, et al. Screening of infants and mortality due to neuroblastoma. N Engl J Med. 2002;346:1041–6.

    Article  PubMed  Google Scholar 

  54. Nishihira H, Toyoda Y, Tanaka Y, et al. Natural course of neuroblastoma detected by mass screening: a 5-year prospective study at a single institution. J Clin Oncol. 2000;18:3012–7.

    PubMed  CAS  Google Scholar 

  55. Hendry GMA. Cystic neuroblastoma of the adrenal gland—a potential source of error in ultrasound diagnosis. Pediatr Radiol. 1982;12:204–6.

    Article  PubMed  CAS  Google Scholar 

  56. Atkinson GS ZG, Lorenzo RI. Cystic neuroblastoma in infants: radiographic and pathologic features. AJR Am J Roentgenol. 1986;146:113–7.

    Article  Google Scholar 

  57. Burbige K. Prenatal adrenal hemorrhage confirmed by postnatal surgery. J Urol. 1993;150:1866–9.

    Google Scholar 

  58. Strouse P. Antenatal sonographic findings of fetal adrenal hemorrhage. J Clin Ultrasound. 1995;23:442–6.

    Article  PubMed  CAS  Google Scholar 

  59. Forman HP, Leonidas JC, Berdon WE, et al. Congenital neuroblastoma: evaluation with multimodality imaging. Radiology. 1990;175:365–9.

    PubMed  CAS  Google Scholar 

  60. Ho PTC, Estroff JA, Kozakewich H, et al. Prenatal detection of neuroblastoma: a ten-year experience from the Dana-Farber Cancer Institute and Children’s Hospital. Pediatrics. 1993;92:358–64.

    PubMed  CAS  Google Scholar 

  61. Fenart D, Deville A, Donzeau M, et al. Neuroblastoma retroperitoneal diagnostique in utero. J Radiol. 1983;64:359–61.

    PubMed  CAS  Google Scholar 

  62. Acharya S, Jayabose S, Kogan S, et al. Prenatally diagnosed neuroblastoma. Cancer. 1997;80:304–10.

    Article  PubMed  CAS  Google Scholar 

  63. Guglielmi M, De Bernardi B, Rizzo A, et al. Resection of primary tumor at diagnosis in stage IV-S neuroblastoma: does it affect the clinical course? J Clin Oncol. 1996;14:1537–44.

    PubMed  CAS  Google Scholar 

  64. Nickerson HJ, Matthay KK, Seeger RC, et al. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children’s Cancer Group study. J Clin Oncol. 2000;18:477–86.

    PubMed  CAS  Google Scholar 

  65. Siegel MJG, Ishwaran H, Fletcher BD, et al. Staging of neuroblastoma at imaging: report of the radiology diagnostic oncology group. Radiology. 2002;223:168–75.

    Article  PubMed  Google Scholar 

  66. Pfluger T, Schmied C, Porn U, et al. Integrated imaging using MRI and 123I metaiodobenzylguanidine scintigraphy to improve sensitivity and specificity in the diagnosis of pediatric neuroblastoma. AJR Am J Roentgenol. 2003;181:1115–24.

    Article  PubMed  Google Scholar 

  67. Kornreich L, Horev G, Kaplinsky C, et al. Neuroblastoma: evaluation with contrast enhanced MR imaging. Pediatr Radiol. 1991;21:566–9.

    Article  PubMed  CAS  Google Scholar 

  68. Shulkin BL, Shapiro B, Hutchinson RJ. Iodine-131-metaiodobenzylguanidine and bone scintigraphy for the detection of neuroblastoma. J Nucl Med. 1992;33:1735–40.

    PubMed  CAS  Google Scholar 

  69. Siegel MJ, Jamroz GA, Glazer HS, Abramson CL. MR imaging of intraspinal extension of neuroblastoma. J Comput Assist Tomogr. 1986;10:593–5.

    Article  PubMed  CAS  Google Scholar 

  70. Tanabe M, Yoshida H, Ohnuma N, et al. Imaging of neuroblastoma in patients identified by mass screening using urinary catecholamine metabolites. J Pediatr Surg. 1993;28:617–21.

    Article  PubMed  CAS  Google Scholar 

  71. Couanet DGA, Hartmann O, et al. Bone marrow metastases in children’s neuroblastoma studied by magnetic resonance imaging. Prog Clin Biol Res. 1988;27:547–55.

    Google Scholar 

  72. Dietrich RKH, Lenarsky C, et al. Neuroblastoma: the role of MR imaging. AJR Am J Roentgenol. 1987;148:937–42.

    Article  PubMed  CAS  Google Scholar 

  73. Ruzal-Shapiro CBW, Cohen M, Abramson S. MR imaging of diffuse bone marrow replacement in pediatric patients with cancer. Radiology. 1991;181:587–9.

    PubMed  CAS  Google Scholar 

  74. Tanabe M, Ohnuma N, Iwai J, et al. Bone marrow metastasis of neuroblastoma analyzed by MRI and its influence on prognosis. Med Pediatr Oncol. 1995;24:292–9.

    Article  PubMed  CAS  Google Scholar 

  75. Tanabe M, Takahashi H, Ohnuma N, et al. Evaluation of bone marrow metastasis of neuroblastoma and changes after chemotherapy by MRI. Med Pediatr Oncol. 1993;21:54–9.

    Article  PubMed  CAS  Google Scholar 

  76. Lebtahi N, Gudinchet F, Nenadov-Beck M, et al. Evaluating bone marrow metastasis of neuroblastoma with iodine-123-MIBG scintigraphy and MRI. J Nucl Med. 1997;38:1389–92.

    PubMed  CAS  Google Scholar 

  77. Brody AS, Frush DP, Huda W, et al. Radiation risk to children from computed tomography. Pediatrics. 2007;120:677–82.

    Article  PubMed  Google Scholar 

  78. Achatz MI, Hainaut P, Ashton-Prolla P. Highly prevalent TP53 mutation predisposing to many cancers in the Brazilian population: a case for newborn screening? Lancet Oncol. 2009;10:920–5.

    Article  PubMed  Google Scholar 

  79. Podrasky AE, Stark DD, Hattner RS, et al. Radionuclide bone scanning in neuroblastoma: skeletal metastases and primary tumor localization of 99mTc-MDP. AJR Am J Roentgenol. 1983;141:469–72.

    Article  PubMed  CAS  Google Scholar 

  80. Bouvier JF, Philip T, Chauvot P, et al. Pitfalls and solutions in ­neuroblastoma diagnosis using radiciodine MlBG: an experience with 50 cases. Prog Clin Biol Res. 1988;271:707–20.

    PubMed  CAS  Google Scholar 

  81. Vik TA, Pfluger T, Kadota R, et al. (123)I-mIBG scintigraphy in patients with known or suspected neuroblastoma: results from a prospective multicenter trial. Pediatr Blood Cancer. 2009;52:784–90.

    Article  PubMed  Google Scholar 

  82. Brodeur GM. Molecular pathology of human neuroblastomas [review]. Semin Diagn Pathol. 1994;11:118–25.

    PubMed  CAS  Google Scholar 

  83. Sharpe S, Shulkin BL, Gelfand MJ, et al. 123I-MIBG-scintigraphy and 18F-FDG PET in neuroblastoma. J Nucl Med. 2009;50:1237–43.

    Article  Google Scholar 

  84. Shulkin BL, Hutchinson RJ, Castle VP, et al. Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy. Radiology. 1996;199:743–50.

    PubMed  CAS  Google Scholar 

  85. Taggart DR, Han MM, Quach A, et al. Comparison of iodine-123 metaiodobenzylguanidine (MlBG) scan and [8F] fluorodeoxyglucose positron emission tomography to evaluate response after iodine 131 MlBG therapy for relapsed neuroblastoma. J Clin Oncol. 2009;27:5343–9.

    Article  PubMed  CAS  Google Scholar 

  86. Kushner BH, Yeung H, Larson SW, et al. Extending positron emission tomography scan utility to high risk neuroblastoma: flourine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients. J Clin Oncol. 2001;19:3397–405.

    PubMed  CAS  Google Scholar 

  87. Hossein J. l-123 MIBG scintigraphy or FDG PET for the imaging of neuroblastoma. J Nucl Med. 2009;50:1237–43.

    Article  Google Scholar 

  88. Manil L, Edeline V, Lumbroso J, et al. Indium-111-pentetreotide scintigraphy in children with neuroblast-derived tumors. J Nucl Med. 1996;37:893–6.

    PubMed  CAS  Google Scholar 

  89. Liou LS, Kay R. Adrenocortical carcinoma in children. Review and recent innovations. Urol Clin North Am. 2000;27:403–21.

    Article  PubMed  CAS  Google Scholar 

  90. McHugh K. Renal and adrenal tumours in children. Cancer Imaging. 2007;7:41–51.

    Article  PubMed  Google Scholar 

  91. Ribeiro RC, Sandrini F, Figueiredo B, et al. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci U S A. 2001;98:9330–5.

    Article  PubMed  CAS  Google Scholar 

  92. Tucci Jr S, Martins AC, Suaid HJ, et al. The impact of tumor stage on prognosis in children with adrenocortical carcinoma. J Urol. 2005;174:2338–42. discussion 2342.

    Article  PubMed  Google Scholar 

  93. Cohen M. Imaging of children with cancer. St. Louis: Mosby Yearbook, Elsevier 1992; p. 134–76.

    Google Scholar 

  94. Elsayes KM, Mukundan G, Narra VR, et al. Adrenal masses: MR imaging features with pathologic correlation. Radiographics. 2004;24 Suppl 1:S73–86.

    Article  PubMed  Google Scholar 

  95. Ciftci AO, Tanyel FC, Senocak ME, et al. Pheochromocytoma in children. J Pediatr Surg. 2001;36:447–52.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgment

I would like to thank Yvette Mingo for her assistance in the manuscript preparation and Carolina Montalvo and Michael Sohn for their assistance in the image preparation.

Author information

Authors and Affiliations

  1. Department of Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA

    Sara J. Abramson M.D., FACR & Anita P. Price M.D.

  2. Department of Radiology, Breast and Imaging Center, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, 10065, USA

    Michael J. Sohn

Authors
  1. Sara J. Abramson M.D., FACR
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anita P. Price M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael J. Sohn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sara J. Abramson M.D., FACR .

Editor information

Editors and Affiliations

  1. Memorial Sloan-Kettering Cancer Center, Department of Radiology, York Avenue 1275, New York, 10065, New York, USA

    Ariadne M Bach

  2. Memorial Sloan-Kettering Cancer Center, Department of Radiology, York Avenue 1275, New York, 10065, New York, USA

    Jingbo Zhang

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Abramson, S.J., Price, A.P., Sohn, M.J. (2013). Pediatric Genitourinary Tumor Imaging. In: Bach, A., Zhang, J. (eds) Atlas of Genitourinary Oncological Imaging. Atlas of Oncology Imaging, vol 1. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4872-3_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-4872-3_10

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-4871-6

  • Online ISBN: 978-1-4614-4872-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation